NewYork Times Report: Experimental Ebola Vaccine Tested in Guinea Shows Promise
An experimental Ebola vaccine being tested in the West African nation of Guinea during the continuing outbreak of the viral disease has shown promising initial results, according to a report on the clinical trial that was published Friday.
NPR News： New Ebola Vaccine Has '100 Percent' Effectiveness In Early Results
In a development that could change the way the deadly Ebola disease is fought, researchers have announced promising results of a new vaccine's trial in Guinea, one of several countries affected by a historic outbreak in West Africa.
Arktek Awarded Prequalified PQS Status by WHO
THE WORLD HEALTH ORGANIZATION (WHO) AWARDED THE AUCMA ARKTEK PASSIVE VACCINE STORAGE DEVICE “PREQUALIFIED” STATUS UNDER ITS “PERFORMANCE, QUALITY AND SAFETY” PROGRAM. PQS PREQUALIFICATION IS A PREREQUISITE FOR MOST GOVERNMENTS IN THE DEVELOPING WORLD FOR SALE AND IMPLEMENTATION OF A DEVICE. IT IS SEEN AS SEAL OF APPROVAL THAT THE PRODUCT HAS BEEN DESIGNED AND TESTED SUCCESSFULLY FOR THEIR REAL WORLD CONDITIONS.